Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_assertion type Assertion NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_head.
- NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_assertion description "[We evaluated AQP4 expression relative to glial fibrillary acidic protein, extent of demyelination, lesion staging (CD68 staining for macrophages), and perivascular deposition of complement and immunoglobulin in 11 cases with NMO and NMO spectrum disorders (NMOSD), five with MS and 30 with other neurological diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_provenance.
- NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_assertion evidence source_evidence_literature NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_provenance.
- NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_assertion SIO_000772 21241398 NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_provenance.
- NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_assertion wasDerivedFrom befree-20140225 NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_provenance.
- NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_assertion wasGeneratedBy ECO_0000203 NP202602.RAcg5EJE-mur-X01ZHUjj4OoKoWgxtSvurGoMuC9vaiGU130_provenance.